Home › NDC Lookup › Ingredients › Pertuzumab, Trastuzumab, And Hyaluronidase-Zzxf
📦 NDC / package directory — not a drug information page

Pertuzumab, Trastuzumab, And Hyaluronidase-Zzxf NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Pertuzumab, Trastuzumab, And Hyaluronidase-Zzxf products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Key stats

4
Package NDCs
2
Products
2
Active listings
0
Discontinued
1
Labelers
2
Strengths
1
Dosage forms
0
With NADAC pricing

By strength, form & labeler

NDC products by strength
PERTUZUMAB 1200 mg/15mL; TRASTUZUM... 1
PERTUZUMAB 600 mg/10mL; TRASTUZUMA... 1
By dosage form
INJECTION, SOLUTION 2
Top labelers
Genentech, Inc. 2

Browse records — 2 products

Drug / product Billing NDC NADAC / unit Status
Phesgo pertuzumab, trastuzumab, and hyaluronidase-zzxf 1200 mg/15mL; 600 mg/15mL; 30000 U/15mL INJECTION, SOLUTION Genentech, · NDC 50242-0245-01 · J9316 · 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-245-01) / 15 mL in 1 VIAL, SINGLE-DOSE 50242-0245-01 — On market View →
Phesgo pertuzumab, trastuzumab, and hyaluronidase-zzxf 600 mg/10mL; 600 mg/10mL; 20000 U/10mL INJECTION, SOLUTION Genentech, · NDC 50242-0260-01 · J9316 · 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-260-01) / 10 mL in 1 VIAL, SINGLE-DOSE 50242-0260-01 — On market View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.